Next Article in Journal
Interaction between Illite and a Pseudomonas stutzeri-Heavy Oil Biodegradation Complex
Previous Article in Journal
Screening Enzymes That Can Depolymerize Commercial Biodegradable Polymers: Heterologous Expression of Fusarium solani Cutinase in Escherichia coli
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

In Vitro Screen of Lactobacilli Strains for Gastrointestinal and Vaginal Benefits

1
IFF Health and Biosciences, 02460 Kantvik, Finland
2
Finnish Red Cross Blood Service, 00310 Helsinki, Finland
3
Vincit Oyj, 20500 Turku, Finland
*
Author to whom correspondence should be addressed.
Microorganisms 2023, 11(2), 329; https://doi.org/10.3390/microorganisms11020329
Submission received: 28 December 2022 / Revised: 21 January 2023 / Accepted: 23 January 2023 / Published: 28 January 2023
(This article belongs to the Section Gut Microbiota)

Abstract

:
Traditional probiotics comprise mainly lactic acid bacteria that are safe for human use, tolerate acid and bile, and adhere to the epithelial lining and mucosal surfaces. In this study, one hundred commercial and non-commercial strains that were isolated from human feces or vaginal samples were tested with regards to overall growth in culture media, tolerance to acid and bile, hydrogen peroxide (H2O2) production, and adhesion to vaginal epithelial cells (VECs) and to blood group antigens. As a result, various of the tested lactobacilli strains were determined to be suitable for gastrointestinal or vaginal applications. Commercial strains grew better than the newly isolated strains, but tolerance to acid was a common property among all tested strains. Tolerance to bile varied considerably between the strains. Resistance to bile and acid correlated well, as did VEC adhesion and H2O2 production, but H2O2 production was not associated with resistance to bile or acid. Except for L. iners strains, vaginal isolates had better overall VEC adhesion and higher H2O2 production. Species- and strain-specific differences were evident for all parameters. Rank-ordered clustering with nine clusters was used to identify strains that were suitable for gastrointestinal or vaginal health, demonstrating that the categorization of strains for targeted health indications is possible based on the parameters that were measured in this study.

1. Introduction

Probiotics are defined as “live microorganisms that, when administered in adequate amounts, confer a health benefit on the host” [1]. Strains of lactic acid bacteria and bifidobacteria are the most frequently used probiotics and have been recognized as safe for human consumption [2]. In addition to safety aspects, a good probiotic, if taken orally, must survive passage through the gastrointestinal tract. Thus, an effective oral probiotic should tolerate and endure the harsh acidic conditions of the stomach and bile in the small intestine [3]. Generally, probiotics confer their benefits by improving epithelial barrier function, increasing adherence to the mucosa, and competing with pathogens for sites of adherence, resulting in competitive pathogenic exclusion, the production of antimicrobial substances and bacteriocins, and modulation of the immune system [4]. Traditionally, probiotics have been used for their gastrointestinal effects and immunomodulatory functions, but increasing evidence has shown their benefits in improving the general health and well-being of a host beyond the gastrointestinal tract [5].
The vaginal microbiota has the lowest taxonomic diversity of any site in the body [6]. In most women of reproductive age, the vagina harbors the highest relative abundance of lactobacilli, comprising more than 20 species, with a predominance of only one or two species in a given sample, the most common being Lactobacillus (L.) crispatus, L. iners, L. jensenii, and L. gasseri [7,8]. In the vaginal tract, lactobacilli create a protective barrier against vaginal infections by maintaining low vaginal pH levels through the production of lactic acid and antimicrobials, such as hydrogen peroxide (H2O2) and bacteriocins [9]. Furthermore, vaginal lactobacilli inhibit pathogenesis by preventing adhesion through competitive exclusion and competition for nutrients [9]. A vaginal microbiota that is rich in lactobacilli species, such as L. crispatus, L. gasseri, and L. jensenii, is often associated with a lower risk of vaginal dysbiosis, i.e., bacterial vaginosis (BV) and other vaginal infections, as well as healthy reproduction [8,10]. However, not all lactobacilli strains confer these benefits, and some benefits are strain-dependent, rendering them effective only for certain disease conditions or pathogens [9,11].
The so-called secretors—individuals who express fucosyltransferase 2 (FUT2)—express blood group determinants (ABO blood group antigens) on mucus and mucosal cells in the intestine and vagina. These antigens are not present in non-secretor individuals who lack FUT2 [12]. The composition of fecal bifidobacteria differs substantially between secretors and non-secretors, the latter of whom harbor lower amounts and fewer species in feces than secretors [13]. Secretor status and FUT2 polymorphisms have been suggested to affect the composition of the gut microbiota [14]; thus, the characteristics of adhesion to specific blood group antigens can be used to develop personalized adhesive probiotics, i.e., strains that interact with particular blood group determinants.
In this study, we screened 100 Lactobacillus sensu lato strains with regard to their tolerance to acid and bile, as well as their ability to grow in de Man–Rogosa–Sharpe (MRS) medium. We also measured parameters that are related to vaginal health, such as H2O2 and adhesion to vaginal epithelial cells (VECs), as well as studied their adherence to blood group antigens to determine strain- and host-specific differences in adhesion. By statistical clustering, we found that it is possible to classify lactobacilli strains as “classical” gastrointestinal probiotics with good tolerance to acid and bile or as probiotics for vaginal health with good vaginal cell adhesion and H2O2 production. The strains also showed strain-specific differences, highlighting the uniqueness of each strain.

2. Materials and Methods

2.1. Bacterial Strains

A total of 100 strains were screened (Table 1), most of which were Lacticaseibacillus rhamnosus (20 strains), followed by Lactobacillus acidophilus (15), Limosilactobacillus fermentum (10), L. crispatus (9), Lacticaseibacillus paracasei (7), and L. jensenii and L. gasseri (6 each). The remaining strains had 5 or fewer members each.
Fifty isolates were sourced from the fecal samples of healthy Finnish adult volunteers (ethical permission 229/E0/07, Helsinki University Hospital EC). A total of 35 strains were obtained from the Danisco Global Culture Collection (DGCC, Niebüll, Germany), containing commercialized (15 strains) and non-commercial strains (20 strains) with dairy, plant, fecal, or unknown origin, all of which were arbitrarily selected based on their lactobacilli status.
A total of 15 strains were isolated from the vaginal tract of asymptomatic healthy Swedish women according to Amsel criteria with a pH of 4.1 (kindly donated by Dr. Inger Mattsby-Baltzer, University of Gothenburg, Gothenburg, Sweden) (Table 1): 5 L. crispatus, 5 L. iners, and 5 L. jensenii. Of the 5 L. iners strains, 2 failed to grow under laboratory conditions and were therefore omitted from the data analysis. In total, 98 strains were tested for general growth, tolerance to acid and bile, VEC adhesion, H2O2 production, and adherence to blood group antigens.
The comparator strains were as follows: L. rhamnosus GG (VTT E-96666, VTT Culture Collection, Espoo, Finland) for acid and bile tolerance; L. jensenii DSM20557 (Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSMZ), Braunschweig, Germany) for H2O2 production; and L. crispatus LMG18199 (JCM8778) (Laboratorium voor Microbiologie, Universiteit Gent, Ghent, Belgium), which is known to adhere well to the A antigen [15], for adhesion to the A, B, and H antigens. In a screen, L. jensenii LX11796 adhered well to VECs and was therefore selected as a comparator strain for the VEC adhesion assay.

2.2. Acid and Bile Tolerance

The tolerance of all strains to acid was tested at pH 2.5 and pH 3.5 for 1.5 h, and tolerance to bile was measured in the presence of 0.9% and 0.3% oxgall (Difco, Fisher Scientific, Vantaa, Finland) for 24 h [16]. In these assays, L. rhamnosus GG was included for comparison based on its ability to survive and proliferate at gastric pH and in bile-containing medium [17].
Briefly, the strains were cultured in duplicate in MRS broth under anaerobic conditions at 37 °C for 18 h. Next, the bacteria were collected by centrifugation at 2800× g for 10 min. The pelleted cells were washed twice with 10 mL phosphate-buffered saline (PBS 0.01 mol/L; pH 7.2, Thermo Fisher Scientific, Waltham, MA, USA) and resuspended in PBS to an optical density at 600 nm (OD600) of 1 (equaling approximately 1 × 108 colony-forming units (CFU)/mL).
Acid tolerance was tested by incubating cells in PBS at pH 2.5, 3.5, and 7.2 for 90 min at 37 °C. Tenfold dilution series were grown on MRS agar, and colonies were counted after a 48 h incubation under anaerobic conditions at 37 °C. The results are expressed as log reduction in growth in CFU at pH 2.5 and 3.5 versus pH 7.2.
Bile tolerance was tested by incubating diluted (1:10) strain cultures in MRS broth that contained 0%, 0.3%, or 0.9% oxgall at 37 °C for 24 h under anaerobic conditions. Growth was measured before and after incubation as OD595 on a Multiskan RC (Labsystems Oy, Vantaa, Finland). The results are expressed as % growth (OD600) in MRS with 0.9% or 0.3% oxgall versus without bile.

2.3. Hydrogen Peroxide Production

The strains were cultured overnight in MRS broth under microaerophilic conditions at 37 °C. OD600 absorbance was then measured on a Multiskan RC, averaging 2.2 (range: 1.8 to 2.4). For the H2O2 assay, 1 mL of the culture was inoculated in 10 mL MRS broth and incubated under aerobic conditions for 3 h at 37 °C to induce H2O2 production. A 50 μL sample was taken from the aerated culture at the start of the incubation (0 h) and after 1.5 and 3 h. H2O2 in the 50 μL sample was measured using a hydrogen peroxide fluorometric detection kit (AH diagnostics Oy, Helsinki, Finland) according to the manufacturer’s instructions. Briefly, 50 μL of reaction cocktail was added to the 50 μL sample and incubated for 10 min in the dark at room temperature, after which the fluorescence was measured on a Wallac Viktor2 1420 multilabel counter (Perkin Elmer, Turku, Finland). Results are expressed as H2O2 production after 0 h, 1.5 h, and 3 h fermentation versus the reference strain, L. jensenii DSM20557. All measurements were performed in duplicate.

2.4. Adhesion to A, B, and H Antigens

The blood group antigens A, B, and H (H antigen corresponding to blood group O phenotype) (Elicityl, Crolles, France) were suspended in PBS at pH 7.2 and biotinylated. The strains were cultured on MRS plates under anaerobic conditions at 37 °C for 48–72 h. A single colony was used to reinoculate 10 mL MRS broth and cultured overnight under anaerobic conditions at 37 °C. The cells were washed twice with 10 mL PBS (pH 7.2) and resuspended in PBS to an OD600 of 1 (approximately 1 × 108 CFU/mL).
Then, 1 mL of bacterial sample and 1 mL 10 µg/mL biotinylated antigen solution were mixed and incubated with slow shaking for 30 min at room temperature, and 100 µL of this mixture was transferred to Delfia streptavidin-coated 96-well plates (Perkin Elmer). The plates were washed twice with 200 µL PBS at pH 7.2 three times with SuperBlock (twice with 200 µL and once with 100 µL) (ThermoFisher Scientific, Pierce™, Waltham, MA, USA) and once with 200 µL sterile water. The plates were then incubated for 30 min at room temperature with slow agitation, after which each well was washed 3 times with 200 µL sterile water for 5 min each. To detect the attached bacteria, 200 µL Syto9 dye (diluted 1:6) (Invitrogen) was added to each well and incubated for 15 min in the dark. The intensity of the dye was measured on a Wallac Viktor2 1420 multilabel counter; all measurements were performed in quadruplicate, and the results were repeated at least twice.

2.5. Adhesion to VECs

Primary VECs were obtained from healthy adult donors (age not specified) (CelProgen, San Pedro, CA, USA), maintained at 37 °C in a 5% CO2 atmosphere, and expanded in human vaginal epithelial expansion ECM T75 flasks (CelProgen) in human VEC growth media with serum (CelProgen). The cells were used in the adhesion assays at the earliest passage possible.
For the adhesion assays, 150,000 VECs were seeded in human vaginal epithelial cell culture ECM 24-well plates (CelProgen). After overnight incubation at 37 °C in 5% CO2, the cells were washed 2 times with Dulbecco’s Modified Eagle Medium (DMEM, Thermo Fisher Scientific) without supplements. Radioactively labeled bacteria (see below) were then applied to the cells and incubated for 1 h to attach. The cells were washed 4 times with PBS at pH 7.2 to remove unattached bacteria, after which 100 µL DMEM and 1 mL Optiphase Supermix (Perkin Elmer) were pipetted onto the cells.
The bacterial strains were labeled radioactively by transferring 1% inoculation from overnight cultures into 1.5 mL MRS with 10 µL methyl-1.2 [3H]thymidine (4.4 TBq/mmol) (Perkin Elmer) and anaerobically cultured overnight at 37 °C. The next day, the bacteria were collected by centrifugation at 2800× g for 5 min, and the bacterial pellet was suspended in PBS and washed twice with PBS. The bacterial quantity was determined by flow cytometry as previously described [18]. Then, 10 bacteria per vaginal cell were centrifuged and diluted with DMEM (Thermo Fisher Scientific™). The number of bacteria in the adhesion experiments was determined in an initial optimization screen with 7 strains (data not shown).
The radioactivity was counted on a 1450 Microbeta Trilux liquid scintillation and luminescence counter (Perkin Elmer). The adhesion for each bacterium was calculated as follows:
% A d h e s i o n = S a m p l e   v a l u e c o n t r o l   1 c o n t r o l   2 c o n t r o l   3 × 100
where:
  • Control 1 contained VECs but no bacteria;
  • Control 2 contained the same number of bacteria but no VECs, which represents the maximum radioactive count that can be obtained from a sample;
  • Control 3 comprised empty wells without bacteria or VECs.
Because L. jensenii LX11796 (Table 1) showed good adhesion, with 5.9% (±2.7) of bacteria adhering to VECs, it was selected as a comparator strain. Thus, relative adhesion was calculated as the ratio of the % adhesion of the sample to the mean % adhesion value of the comparator.

2.6. Statistical Methods

Species were compared using a Welch t-test (row vs. column). FDR adjustment was performed using the Benjamini–Hochberg procedure (supplemental Tables S1–S6). In these analyses, species with fewer than 3 strains (Lactococcus lactis, L. amylovorus, L. casei, L. curvatus, L. delbrueckii, L. helveticus, L. johnsonii, L. mucosae, L. reuteri, L. ruminis, and L. salivarius) were omitted from the analysis.
Spearman correlation was performed to assess the statistical dependence between measurement pairs. The statistical significance of Spearman correlation coefficients was calculated using GraphPad Prism, version 9.2.0 (GraphPad Software, La Jolla, CA, USA), and p values < 0.05 were considered significant.
The adhesion data for antigens A, B, and C were standardized separately to 0 mean and unit variance for descriptive purposes.
Part of the analysis was performed using rank-transformed data that were derived by rank ordering the strains based on a measurement, then by replacing the measured value by the rank of the strain such that the best-performing strain was assigned a value of 1 and the worst-performing strain was assigned a value of 98. As not all strains produced H2O2, the maximum value of H2O2 production either at 0 h, 1.5 h, or 3 h was taken for ranking. The benefit of this approach includes the ability to compare and visualize the measurements. The strains were clustered by Euclidean distance in the rank-transformed data using Ward’s method [19]. The resulting tree was pruned into 9 clusters for descriptive purposes.
The statistical significance of comparisons between strain groups using ranked data was calculated by the Kruskal–Wallis rank sum test [20] (Supplementary Materials Figures S7–S10).
Statistical analyses were performed in R (version 4.0.3) and with GraphPad Prism (version 9.2.0).

3. Results

3.1. Growth

The ability to grow in MRS broth was tested for the entire panel of strains. At the species level, most species grew well in MRS, although high variation was observed in certain species (Figure 1A). The only species that did not grow in MRS were two strains of L. iners (Li25-34 and Li22-26), which were therefore excluded from further studies. In addition, according to optical density measurements, the other L. iners strains grew more poorly than the other species, with the exception of L. gasseri (Table S1).
At the strain level (Supplementary Materials Figure S1), L. rhamnosus LX11888 showed the highest variation in growth amongst individual strains. The 10 worst-growing strains in MRS were the 3 L. iners strains, L. amylovorus LX11898, L. mucosae LX11854, Latilactobacillus curvatus 360, L. fermentum 508, L. rhamnosus LX11870, L. gasseri LG11876, and L. crispatus LX11211. None of the poor performers was a commercial strain. The 10 best growers in MRS were the commercial strains L. salivarius Ls-33, L. plantarum Lp-115, L. rhamnosus HN001, and Lacticaseibacillus casei Lc-11, in addition to the non-commercial strains L. plantarum LX11878 and LX11861, L. rhamnosus 1704 and LR1049, L. fermentum LX1312, and Lacticaseibacillus paracasei LX11858.

3.2. Acid Tolerance

Acid tolerance of the 98 strains in MRS was tested by growing them at pH 2.5 and pH 3.5; the logarithmic reduction in growth was normalized to the growth at pH 7.2 (Figure 1B,C). Acid tolerance of L. rhamnosus GG was used for comparison. The acid tolerance at pH 2.5 correlated positively with that at pH 3.5 (pairwise Spearman correlation, r = 0.2782 and p = 0.0066 (data not shown)).
The acid tolerance varied widely between species, but many tolerated the milder acidic conditions at pH 3.5 well (Figure 1B), particularly L. rhamnosus, L. acidophilus, L. fermentum, L. paracasei, L. gasseri, and L. crispatus (with the exception of one strain). L. jensenii had the highest variation among species, with lower tolerance to acid, and did not significantly differ from L. fermentum (Table S2). The other significant differences were between L. acidophilus and L. rhamnosus, as well as between L. fermentum and L. plantarum (Table S2), which indicates that the various species tolerated mild acid quite well.
Eighty-seven strains showed high survival in acid at pH 3.5 (less than 0.5 log reduction) (Supplementary Materials Figure S2A), with an average log reduction of 0.26 (SD ± 0.57) compared to L. rhamnosus GG (−0.08 ± 0.23). Viability at pH 3.5 decreased by more than 2 logs for only four strains: L. jensenii LX11794, L. crispatus LX11211, L. curvatus 360, and L. jensenii LX12217.
At pH 2.5 (Figure 1C), all six L. gasseri strains were among those that tolerated acid the best (log reduction < 1). Indeed, L. gasseri was significantly more tolerant than all other species (Table S3). L. acidophilus species tolerated acid at pH 2.5 quite well and were significantly more tolerant than L. crispatus, L. plantarum, and L. jensenii (Table S3). Similarly, L. paracasei and L. rhamnosus were more tolerant than L. crispatus and L. jensenii (Table S3). Visually, L. amylovorus and L. brevis strains also performed poorly, and L. johnsonii was the best-performing in terms of acid tolerance, although the number of strains was too low for proper statistical analysis (Figure 1C and Table S3).
At pH 2.5, viability decreased by more than 2 logs in 83 strains (Supplementary Materials Figure S2B), and the tolerance varied more widely than at pH 3.5; the average reduction in viability was 2.96 (SD ± 1.34). Compared with L. rhamnosus GG, which underwent a log reduction of 2.27 (SD ± 0.35), 23 strains were more tolerant to acid at pH 2.5 (Supplementary Materials Figure S2B). A log reduction of more than 5 was noted in L. acidophilus LA0893, L. jensenii LX12216, L. crispatus LX1307, L. jensenii LX11796, L. brevis LX11860, L. jensenii LX11795, L. jensenii LX12217, and L. amylovorus LX11898.

3.3. Bile Tolerance

To test the bile tolerance of the strains, their growth in MRS was compared with and without bile using L. rhamnosus GG as the comparator. The tolerance to 0.3% and 0.9% bile correlated positively (pairwise Spearman correlation, r = 0.858 and p < 0.0001 (data not shown)). Furthermore, in the Spearman correlation analysis, the tolerance to acid at pH 2.5 correlated positively to 0.3% and 0.9% bile tolerance (r = 0.223, p = 0.027 and r = 0.216, p = 0.033, respectively (data not shown)).
At the species level, the variation was much higher at milder (0.3%) (Figure 1D) versus 0.9% bile (Figure 1E), and the bacteria generally tolerated 0.3% bile well and similarly to the comparator strain. The weakest-performing species in 0.3% bile (Figure 1D) was L. jensenii, with significantly worse performance than the rest of the species, with the exception of L. iners (Table S4). Likewise, L. crispatus grew poorly in 0.3% bile and performed significantly worse than every other species, except L. paracasei, L. gasseri, and L. iners (Table S4). The best-performing species in 0.3% bile was L. mucosae, with its two strains, but only visually. Statistically, the best-performing species was L. acidophilus, which performed better than L. paracasei, L. rhamnosus, L. crispatus, and L. jensenii (Figure 1D and Table S4).
At the strain level, in 0.3% bile (Supplementary Materials Figure S3A), 40 strains performed better than L. rhamnosus GG, and survival in 31 strains decreased by more than 50%. Twelve strains had a survival rate of 10% or lower.
In 0.9% bile (Figure 1E), two distinct groups appeared: one with better tolerance, comprising L. acidophilus, L. iners, L. plantarum, L. brevis, L. amylovorus, and L. mucosae, exceeding the survival of L. rhamnosus GG; and one of less tolerant species, with survival rates at or below that of the comparator, including L. rhamnosus, L. fermentum, L. crispatus, L. paracasei, L. gasseri, L. jensenii, and L. johnsonii. Indeed, L. acidophilus species performed significantly better than any other species except L. brevis, L. plantarum, and L. iners (Table S5), and similarly, L. plantarum performed better than any other species except for L. acidophilus, L. brevis, L. fermentum, and L. iners (Table S5).
In 0.9% bile, 36 strains performed better than L. rhamnosus GG, and survival in 69 strains decreased by more than 50%. A total of 22 strains had survival rates of 10% or less (Supplementary Materials Figure S3B).

3.4. Hydrogen Peroxide Production

H2O2 production by each strain was measured after 1.5 h and 3 h of incubation, expressed as a percentage versus the comparator L. jensenii DSM 20557 [21]. H2O2 production correlated strongly between the two time points (pairwise Spearman correlation, r = 0.788, p < 0.0001 (data not shown)). Of the 98 tested strains, only 50 produced H2O2 after 1.5 h; therefore, only the H2O2 production after 3 h was more closely investigated at the species level. Notably, H2O2 production at 1.5 h correlated negatively with acid tolerance at pH 2.5 (r = −0.230, p = 0.023 (data not shown)) and pH 3.5 (r = −0.312, p = 0.002 (data not shown)) and with bile tolerance at 0.3% (r = −0.229, p = 0.023 (data not shown)) and 0.9% oxgall (r = −0.259, p = 0.01 (data not shown)) and positively with VEC adhesion (r = 0.201, p = 0.048 (data not shown)). Similarly, H2O2 production at 3 h had an inverse relationship with acid tolerance at pH 2.5 (r = −0.227, p = 0.025 (data not shown)) and pH 3.5 (r = −0.304, p = 0.003 (data not shown)) and with bile tolerance at 0.3% (r = −0.207, p = 0.041 (data not shown)).
H2O2 production varied highly within species, indicating strain-specific differences. All L. acidophilus, L. jensenii, L. gasseri (excluding L. gasseri Lg-36), and L. crispatus strains (excluding L. crispatus LX11211) produced H2O2 at 3 h, whereas L. rhamnosus, L. johnsonii, L. paracasei, and L. plantarum strains generated little, if any (Figure 1F). L. fermentum strains were variable in production, as some strains produced relatively high amounts, whereas some did not produce at all (Figure 1F). Furthermore, vaginal isolates of L. iners strains synthesized limited H2O2 compared to other vaginal isolates. L. crispatus and L. jensenii. L. jensenii produced the highest mean concentration of H2O2 at 3 h, which was significantly better than almost every other species, except for L. acidophilus and L. crispatus (Figure 1F and Table S6). Additionally, apart from low-producing outliers, L. crispatus generated substantial amounts of H2O2 and performed better than every other species except L. acidophilus, L. fermentum, L. gasseri, and L. jensenii (Table S6).
The number of strains that produced H2O2 increased from 50 to 62 after 3 h incubation (Supplementary Materials Figure S4). H2O2 production was undetectable in 36 strains. A total of 23 strains performed better than the comparator at 3 h: 6 L. jensenii, 5 L. acidophilus, 5 L. crispatus, 5 L. gasseri, Ligilactobacillus ruminis LX11894, L. amylovorus LX11898, L. delbrueckii subsp. bulgaricus Lb-64, Lactococcus lactis Ll-23, and L. fermentum LX11865 strains (Supplementary Materials Figure S4). Almost all vaginal isolates produced H2O2 and were among the top 23 strains performing better than L. jensenii DSM 20557, with the exception of L. crispatus LX11211 and all L. iners strains, which produced limited H2O2, and L. crispatus LX12212, which generated 97% of the H2O2 levels produced by the control strain.

3.5. Adhesion to VECs

The adhesion of bacteria to primary VECs was measured by applying them to VECs at a ratio of 10 tritium-labeled lactobacilli to 1 VEC and by incubating them for 1 h, after which adhered bacteria were counted after washing away the unadhered bacteria. To compare the results between experiments, adhesion in each assay was normalized to that of the comparator strain, L. jensenii LX11796. The adhesion to VECs correlated positively with H2O2 production at 1.5 h (Spearman r = 0.201, p = 0.048 (data not shown)) and negatively with tolerance to 0.3% bile (Spearman r = −0.222, p = 0.029 (data not shown)).
At the species level (Figure 1G), the adhesion was quite uniform. L. brevis, with its three strains, seemed to adhere the best to the cells, whereas L. iners represented the least adherent species. However, when analyzed statistically, no statistical differences were detected among strains (Table S7).
At the strain level, the bacteria exhibited wide range of adhesion (Supplementary Materials Figure S5). The top 15 strains that adhered the best to VECs included 3 L. rhamnosus strains (LR1049, LX11875, and LX11881), 3 L. jensenii strains (LX11795, 911, and LX11796), and 3 L. crispatus strains (LX1220, LX11797, and LX11799). L. reuteri 1753, two L. brevis strains (LX11860 and LX11864), L. paracasei LX11887, and L. crispatus LX11799 adhered better than or equal to the comparator strain. As the comparator strain in the screen was not a commercial or type strain, it was difficult to determine how well the bacteria adhered compared with a benchmark. However, the strain utilized as comparator was adhered better than the commercial strains in the panel.

3.6. Adhesion to Blood Group Antigens A, B, and H

The adhesion of the strains to blood group antigens A, B, and H was measured by in vitro assay using biotinylated antigens and compared with the comparator strain, L. crispatus LMG18199, which adheres well to the A antigen [22]. The specificity for the antigens was low, and most strains adhered similarly to all tested antigens. The adhesiveness also correlated strongly between antigens (pairwise Spearman correlation r = 0. 819 between adhesion to A and B, r = 0.700 between A and H, and r = 0.788 between B and H; p < 0.0001 for all (data not shown)). These values did not correlate well with the other measured parameters in the Spearman correlation analysis.
At the species level, all species adhered to the antigens at similar levels (Figure 1H–J). L. fermentum, L. paracasei, and L. plantarum species showed the highest variation between strains; therefore, some strains from these species displayed differences in adherence to the antigens. However, statistical significance was only observed between L. rhamnosus and L. crispatus, L. gasserii, L. jensenii, and L. iners, with higher adhesion to all blood type antigens (Tables S8–S10). Furthermore, L. rhamnosus was significantly more adhesive compared to L. paracasei in the case of antigen H adhesion (Table S10).
Some strains showed high variation in their adherence to antigens, whereas others did not adhere or did so to a limited extent (Supplementary Materials Figure S6A–C). Five strains showed better adhesion to the A antigen than the comparator strain: L. paracasei LX11858, L. fermentum LX11866, L. fermentum LX11865, L. fermentum LX11852, and L. fermentum LX11853 (Supplementary Materials Figure S6A), of which the latter four also adhered to B and H antigens better than the comparator strain (Supplementary Materials Figure S6B,C).
Plotted together (Figure 2A), the adhesion values correlate well between antigens, indicating that a strain with strong A-antigen adhesion is also likely to have strong B- and H- antigen adhesion, as indicated above. When adhesion values were standardized for each antigen to a comparable scale by setting their standard deviations to 1, the adhesion was remarkably similar for each strain (Figure 2B). Several exceptions were observed, particularly when the standardized adhesions within each strain were examined. The 10 strains with the highest standard deviations (SD > 0.58) and, most likely, the highest specificity for a certain blood group antigen (Figure 2C) were 6 L. rhamnosus strains (LX11870, HN001, LX11867, Lr-32, LX11874, and LX11877), 3 L. paracasei strains (LX11858, LX11885, and LX11849), and L. acidophilus LA11884. In contrast, the 10 least-varying strains (SD < 0.03) and, most likely, adhering similarly to all blood group antigens were the 2 strains of L. amylovorus (LX11891 and LX11898), 2 strains of L. gasseri (LG11876, LG11895), 2 strains of L. mucosae (LX11893 and LX11854), L. helveticus LH0138, L. acidophilus LX11850, L. crispatus LX11797, and L. rhamnosus LX11851 (data not shown). The 10 strains with the highest median adhesion values to the 3 antigens (Figure 2D) were 5 L. rhamnosus strains (LX11877, LR1049, LX11857, LX11869, and LX11881), 4 L. fermentum strains (LX11866, LX11865, LX11852, and LX11853), and L. plantarum LX11861.

Differences in Commercial Strains and Vaginal Isolates

Next, the data were rank-ordered and analyzed as groups (fecal versus non-fecal isolates, commercial versus non-commercial, and vaginal versus non-vaginal). In the rank ordering, the best-performing probiotic was assigned a value of 1, increasing in value for each strain to 98, with the exception of ranking based on H2O2 production (see Section 2.3). The rank-ordered data were also correlated to gastrointestinal and vaginal parameters, and in each correlation analysis, the 10 best-performing probiotics were identified. Generally, with regard to gastrointestinal probiotic characteristics, fecal lactobacilli were the top performers, whereas vaginal isolates predominated when vaginal probiotic characteristics (H2O2 production and adhesion to vaginal epithelial cells) were analyzed.
Compared with non-fecal strains (Supplementary Materials Figure S7), fecal lactobacilli showed better tolerance to 0.3% and 0.9% bile (p = 0.002 and p < 0.001, respectively) and greater adhesion to the A (p < 0.001), B (p = 0.004), and H antigens (p = 0.006). No other significant parameters were noted.
When commercial strains were compared to non-commercial strains, the 15 studied commercial strains grew better in MRS (p = 0.009). Interestingly, the current commercial strains showed less adhesion to VECs than the non-commercial strains (p = 0.030) (Supplementary Materials Figure S8A).
We also projected the rank-ordered data in two dimensions to determine the best-performing strains in each projection. When the rank-ordered data for general growth in MRS and acid tolerance at pH 2.5 were projected, three commercial strains—L. casei Lc-11, L. rhamnosus HN001, and L. rhamnosus Lr-32—were among the 10 best-performing strains (Supplementary Materials Figure S8B). L. rhamnosus strains were generally well represented in growth versus acid tolerance, contributing 6 of the top 10 strains (HN001, Lr-32, LX11882, LX11877, LX11879, and LX11881), with L. gasseri 811, L. johnsonii LG0884, L. casei Lc-11, and L. acidophilus LA11883 constituting the remainder.
Similarly, tolerance to 0.3% and 0.9% bile was projected to acid tolerance at pH 3.5 and pH 2.5 (data not shown; Supplementary Materials Figure S9A). Under the milder conditions (pH 3.5 and 0.3% bile (data not shown)), the best-performing strains were four L. fermentum (238, 508, SBS-1, and 1924), three L. acidophilus (LA11883, LX11873, and LX11850), L. gasseri LG11859, L. salivarius Ls-33, and L. mucosae LX11893. However, when the tolerance data under stronger conditions (pH 2.5 and 0.9% bile) were projected, eight of the best-performing strains were L. acidophilus (NCFM, LA11883, LA11890, LA11892, LA11897, 74-2, LA1076, and LX11873), and the remaining two were L. fermentum 508 and L. reuteri 1753 (Supplementary Materials Figure S9B). Thus, with regard to acid and bile tolerance, L. acidophilus strains were among the best-performing. In this comparison of the rank-ordered data, the top 10 strains at pH 2.5 and 0.9% bile did not show any significant differences in other parameters versus the rest of the strains, and among these strains, only 2 were commercial, i.e., L. acidophilus NCFM and 74-2 (Supplementary Materials Figure S9A).
In addition, the parameters were examined separately for the 13 strains isolated from the vaginal tract and compared with the rest of the strains in the rank-ordered data (Supplementary Materials Figure S10A). Tolerance to acid (p = 0.003 for pH 2.5 and p < 0.001 for pH 3.5) and bile (p = 0.004 for 0.3% and p = 0.002 for 0.9%) was lower in vaginally isolated strains versus the other strains in the panel. Furthermore, these strains produced more H2O2 and adhered better to VECs, albeit insignificantly.
When VEC adhesion was correlated to H2O2 production in the rank-ordered data in the full dataset (Supplementary Materials Figure S10B), the 10 best-performing strains were more diverse in origin, with 4 of vaginal origin (L. crispatus LX11797, L. crispatus LX11798, L. jensenii LX11794, and L. jensenii LX11796). The remainder of the 10 best-performing strains comprised L. crispatus LX1220, L. jensenii 911, L. gasseri 811, L. johnsonii LG0883, L. fermentum LX11865, and L. reuteri 1753. The top 10 strains showed good VEC adhesion and H2O2 production, but they had poor tolerance to mild acid (p = 0.042) and bile (p = 0.003 for 0.3% and p = 0.022 for 0.9%). Thus, if a strain shows good VEC adhesion and H2O2 production or is isolated from the vaginal tract, it does not necessarily have good tolerance to acid or bile.

3.7. Cluster Analysis of Rank-Ordered Data

To better visualize the characteristics of the 98 strains, 9 clusters were created by hierarchical clustering according to Ward’s method (Figure 3A). Each cluster contained various Lactobacillus species, and none contained just one species. Cluster 8 had the most ‘classical’ probiotic characteristics (Figure 3B), with high tolerance to acid and bile and good growth in MRS. In terms of H2O2 production and adhesion to blood group antigens and VECs, the strains in cluster 8 were among the lowest-ranking. This cluster contained the most commercial strains (5 of 14), but otherwise, the commercial strains were distributed across seven clusters, with cluster 5 being the only one without commercial strains. Cluster 1 contained the second highest number of commercial strains (3 of 12), with good acid and bile tolerance but moderate to good rankings for other characteristics, apart from average adherence to VECs. This cluster contained most of the L. acidophilus strains (10 of 15 L. acidophilus strains in the panel).
With regard to the properties of vaginal probiotics, the most notable clusters were clusters 7, 5, and 9, showing high adhesion to VECs and/or high H2O2 production. Additionally, cluster 3 contained strains that produced significant H2O2 and adhered to VECs (Figure 3B). Cluster 5 (five strains) showed the best adherence to blood group antigens A, B, and H (Figure 3B). This cluster contained strains that were low in growth but tolerated bile and mild acidic conditions rather well and produced H2O2 moderately. Cluster 5 comprised L. amylovorus LX11898, L. brevis LX11864, and three L. fermentum (L. fermentum LX11852, L. fermentum LX11853, and L. fermentum LX11865). All of these strains were of fecal origin. The other cluster with good adherence to blood group antigens A, B, and H was cluster 9 (see below), which, likewise, did not contain any vaginal isolates. Strains from cluster 9 also adhered well to all blood group antigens, with good growth acid resistance and moderate bile resistance, but failed to produce H2O2. This cluster contained more than half of the L. rhamnosus strains (11 of 20 in the panel) and two L. paracasei and two L. plantarum strains; however, likewise, none was of vaginal origin.
Cluster 3, containing six different species (L. acidophilus, L. fermentum, L. helveticus, L. delbrueckii bulgaricus, L. jensenii, and L. crispatus) had the opposite profile to cluster 9, producing H2O2 well but adhering poorly to blood group antigens. Most of the L. jensenii strains (four of six strains) resided in this cluster. The other two L. jensenii strains were in cluster 7, with good H2O2 production and VEC adhesion, implying that the L. jensenii species has potential as a probiotic for vaginal health.
The vaginal isolates in the screening panel were distributed among clusters 2, 3, 6, and 7, indicating that lactobacilli from the vaginal tract have varying characteristics. Cluster 7, which was also the largest of the clusters, contained the most vaginal isolates (7 of 16 strains) (L. crispatus LX11211, L. crispatus LX12212, L. crispatus LX11797, L. crispatus LX11798, L. crispatus LX11799, L. jensenii 11794, and L. jensenii LX11795). These strains showed rather good adhesion to blood group antigens and VECs and good H2O2 production but moderate tolerance to acid and bile and growth in MRS.

4. Discussion

To elicit a health benefit, an oral probiotic strain should tolerate acid and bile, show good adhesion to intestinal or vaginal epithelia, depending on the target site, and possess antimicrobial properties. Furthermore, to be produced commercially, the strain should be culturable on a large scale. The aim of this study was to characterize the in vitro probiotic properties of 100 Lactobacillus sensu lato strains that were isolated primarily from the intestinal and vaginal tracts and rank them into various functional groups to determine their suitability for gastrointestinal and vaginal indications. Although important probiotic characteristics, such as H2O2 production, adhesion to vaginal epithelial cells, and bile and acid resistance were measured in this preliminary screening, other important probiotic safety-related properties, such as hemolysis and, most notably, antibiotic resistance [23], were not. Thus, further in-depth safety evaluation of the strains is needed for any future clinical studies, as has been done, for instance, by Pino and coworkers [24]. However, the results obtained in the current study can be utilized as a primary strain selection tool for specific health indications. The results show high strain-specificity in each characteristic tested, and the strains fell into nine variable clusters. The results confirm the widely held notion that probiotic properties are strain-specific [11]. None of the clusters was dominated by a single species. However, the clustering differentiated strains that tolerated bile and acid, indicating their potential for gastrointestinal indications. Furthermore, the clustering identified strains that adhered to vaginal cells and produced H2O2, conferring on them vaginal benefits.
Lactobacilli possess differential surface characteristics and express various enzymes, creating strain and species specificity in their response to environmental conditions and stresses [25]. Bile salts have strong antimicrobial potential, and tolerance to bile determines the ability to survive in the small intestine [26]. Resistance to bile parallels that to other stresses, such as acid and oxidative stress [25,26,27], which we also noted in our study. This tolerance differed based on the strength of such conditions, and our study included strains that varied in their tolerance. The ‘traditional’ probiotic species—L. acidophilus and L. rhamnosus— tolerated the stronger acid and bile conditions consistently, as expected, because the genetic machinery for bile and acid tolerance is well described for Lactobacillus [26]. All 15 L. acidophilus strains and most (16/20) L. rhamnosus strains were fecal in origin, and logically, the fecal isolates tolerated bile better than vaginal isolates in the rank-ordered data because the fecal strains had adapted to the conditions in the gastrointestinal tract.
Overall, the commercial strains were easier to culture, and 4 of the 10 easiest strains to culture were commercial, whereas none of 10 worst performers was. Ease of production, viability, and stability, are the key factors in the selection of commercial probiotics and are important for industrial-scale production. In addition, probiotics need to tolerate various stresses during production [3,28]. Thus, as expected, many of the easiest strains to culture were commercial strains. Conversely, L. iners, L. brevis, L. amylovorus, and L. mucosae, all of which are non-commercial strains, grew poorly in MRS. However, the small number of these strains in the panel might have biased this result; for instance, numerous L. rhamnosus, L. crispatus, and L. fermentum contained both strains that grew well and grew poorly.
Traditionally, adherence has been examined with intestinal epithelial cells, such as Caco-2, or mucus, such as that from pigs or humans [29]. In our study, we used a different approach, measuring the adherence of lactobacilli to histo-blood group antigens A, B, and H, as well as to VECs. The ABO histo-blood group system consists of two antigens (A and B) and four blood types (types A, B, AB, and O), of which group O expresses only H antigen, the biosynthetic precursor of antigens A and B. These antigens are widely expressed in red blood cells and many tissues and secretions, including the gastrointestinal and vaginal mucosae [30]. However, ABH antigens are not present in all individuals; non-secretors lack functional fucosyltransferease-2 and do not express these antigens in their secretions or mucosa, instead expressing Lewis A antigen [31].
Some pathogens and their toxins can bind blood group antigens directly [32], such as H. pylori [33], Norwalk virus [34], norovirus GII.4 genotype [35], and rotavirus [36]. Lactobacilli strains of L. crispatus, L. mucosae, L. plantarum, and L. paracasei express blood group antigen-binding adhesins and therefore may compete in adhesion mechanisms that impede pathogenesis [22,37,38,39,40]. Moreover, blood group antigens, glycans on ABO antigens, and Lewis antigen shed into the intestinal lumen can be fermented by intestinal bacteria such as bifidobacteria and Bacteroides spp.; thus, these glycans can serve as energy sources for bacteria and affect the composition of the gut microbiota [14]. Research shows that the composition of intestinal mucosal microbiota is affected by the ABO blood type and the secretor status of the host [14,41], especially the presence of B antigen [39], although contradictory results have also been reported [42]. However, information on the adhesion properties of probiotics to different blood group antigens could be relevant in the design of personalized probiotics for the market because specific adhesins toward a certain blood group antigen could further increase the colonization potential of probiotics. In our study, strains were differentiated and ranked as having antigen-specific adhesion, non-specific adhesion (similar affinity to all), or equal affinity (highest median adhesion). This categorization could be used to tailor probiotics based on adherence toward a certain blood group antigen or implement a more generic approach that is suitable for most consumers. Among the top 10 strains with the most variability in their adhesion to blood group antigens, 2 were commercial (L. rhamnosus HN001 and L. rhamnosus Lr-32).
It was previously reported that bacterial survival in an upper gastrointestinal experimental model depended on the secretor and non-secretor status of the donor, with bacteria from the latter being more vulnerable to acid and bile [43]. However, we do not know whether the donor from which the fecal strains were isolated was a non-secretor or secretor; thus, ideally, future studies should harvest bacteria from individuals with different blood group antigens and secretor statuses. Notably, fecal strains adhered better to all blood group antigens compared with strains sourced elsewhere. Furthermore, clustering of the rank-ordered data showed that adhesion to antigens A and B by some strains was associated with poor acid and bile tolerance, indicating that they would survive poorly in the upper gastrointestinal tract, although there were still some clusters that had both good acid and bile tolerance and good adhesion to blood group antigens. However, identifying new probiotic candidates solely from among those that best tolerate acid and bile would overlook other beneficial properties. For instance, the production of H2O2, an asset of vaginal lactobacilli, correlated negatively with tolerance to acid and bile. Considering women’s health, such tolerance might be dispensable for intravaginal probiotics, whereas the bacteria in oral supplements would first need to travel through the gastrointestinal tract, resisting the acidity of the stomach and the bile from liver [26]. To this end, encapsulation technologies can be used to overcome such poor survival [44].
Vaginal bacteria can be classified into five main types by community. Four are predominated by Lactobacillus spp.—L. crispatus, L. gasseri, L. iners, and L. jensenii—whereas the fifth comprises a mixed community of strictly anaerobic bacteria [45]. Lactobacilli protect the vaginal mucosa through adherence to the vaginal epithelia and their antimicrobial properties [46]. The production of lactic acid, H2O2, and antimicrobial agents is considered a beneficial attribute of vaginal lactobacilli [9]. Whereas lactic acid inhibits the growth of pathogenic bacteria by lowering pH, the function of H2O2 is not fully elucidated, but it has been suggested to destroy bacteria owing to a lack of H2O2-degrading enzymes such as catalase peroxidase [9,47]. Nevertheless, 70% to 95% of lactobacilli in the vaginal microbiota of healthy women produce H2O2, and the levels of these lactobacilli decrease in women with vaginal infections [48,49,50]. L. gasseri, L. jensenii, and L. crispatus species commonly predominate in the vaginal tracts of healthy women [10], and more than 90% of the strains in these genera produce H2O2 [48]. For instance, at least 80% of isolates of L. jensenii, L. salivarius, L. rhamnosus, and L. vaginalis generate high amounts of H2O2, as does L. gasseri, although to a lesser extent [51]. In our study, 53% (52/98) of strains produced H2O2, the most prominent of which were L. gasseri, L. jensenii, and L. crispatus, whereas L. rhamnosus, L. johnsonii, and L. brevis synthesized lower amounts. However, most strains in the screening panel were of fecal rather than vaginal origin. Most of the vaginal isolates (10/13) produced H2O2, with the exception of L. iners. This was expected because L. iners strains are reported to generate limited amounts of H2O2 [52]. Furthermore, L. iners is not well adapted to grow in MRS, preferring sheep blood agar. L. iners also produce L-lactic acid but not D-lactic acid, which is regarded as a more protective isomer for vaginal health [52]. The function of L. iners in vaginal health is controversial; it is commonly found in healthy women but is also often encountered during vaginal dysbiosis [52,53,54]. Moreover, the L. iners strains adhered poorly to VECs in our study compared with the L. crispatus and L. jensenii strains. Notably, L. iners lack adhesins that are common to other lactobacilli, instead expressing fibronectin-binding protein, which is similar to pathogenic Staphylococcus aureus [52].
In dysbiosis of the vaginal microbiota, such as during BV, lactobacilli are depleted from the vaginal microbiota and are overrun by various facultative anaerobes [55,56]. Probiotic lactobacilli with or without antibiotics administered orally or intravaginally have shown promise in reducing the risk of vaginal infections [55,57,58]. Good adherence of lactobacilli to vaginal epithelia is a potential mechanism for protecting the vaginal mucosa from pathogenesis by inhibiting and interfering with the adhesion of pathogenic microorganisms [46]. In our study, the adhesion of lactobacilli to VECs correlated positively with good H2O2 production. In the rank-ordered data, when the entire dataset was projected according to VEC adhesion and H2O2 production, 4 of the top 10 strains were vaginal in origin, highlighting their potential as probiotics for vaginal health. These vaginal isolates, especially L. jensenii, also showed lower tolerance to acid and bile compared with the rest of the strains. Future studies should compare the responses of less tolerant species, such as L. jensenii, to those with greater tolerance, such as L. acidophilus and L. plantarum, and determine whether gradual exposure to increasing stress improves tolerance in L. jensenii [26].
One drawback of our study is the use of bovine bile (Oxgall), which slightly reduces the pH of culture media [59]. We did not control the pH of the culture medium in the bile tolerance assays, as has been done in some other studies [60]; thus, the lower viability in bile could have been caused by the accumulation of lactic acid and other organic acids that are produced by the bacteria [26]. To survive passage through the gastrointestinal tract, the adaptation of microorganisms to a stressor might enhance survival under another stressor that is encountered [61]. This species-specific cross protection can be beneficial when cells are exposed to a combination of stresses [61], and these adaptive responses can be addressed further in examining the probiotic properties of lactobacilli.
In conclusion, we screened 98 strains for their overall growth in MRS, tolerance to acid and bile, H2O2 production, and adhesion to VECs and blood group antigens. There were clear differences in these characteristics depending on the source of the strain, but there were also strain-dependent properties between species. We found that strains that were of fecal origin adapted better to acidic and high-bile conditions, whereas vaginal strains, with the exception of L. iners, were good H2O2 producers and adhered well to VECs, although some of these strains were less tolerant to acid and bile. Future encapsulation technologies and an improved understanding of the genetic background in the development of tolerance and beneficial properties can guide and improve the selection of probiotics.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/microorganisms11020329/s1, Figure S1: Growth on MRS at the strain level. Figure S2: Acid tolerance at the strain level. Figure S3: Bile tolerance at the strain level. Figure S4: Hydrogen peroxide production at the strain level at 3 hours. Figure S5: Adhesion to vaginal epithelial cells at the strain level. Figure S6: Adhesion to blood group antigens at the strain level. Figure S7: Box plots of measured characteristics of the lactobacilli isolated from feces in comparison to strains of non-fecal origin. Figure S8: Characteristics of the 16 studied commercial probiotics in comparison to non-commercial strains. Figure S9: Characteristics of the 10 best-performing strains with rank-ordered acid (pH 2.5) and strong bile (0.9% oxgall) tolerances in comparison to the other strains in the dataset. Figure S10: Characteristics of the 13 vaginally isolated lactobacilli in comparison to strains from other origins. Table S1: Statistical analysis of growth in MRS OD600. Table S2: Statistical analysis of acid tolerance at pH 3.5 (log reduction). Table S3: Statistical analysis of acid tolerance at pH 2.5 (log reduction). Table S4: Statistical analysis of bile tolerance, growth in 0.3% oxgall, % of growth in MRS w/o bile. Table S5: Statistical analysis of bile tolerance, growth in 0.9% oxgall % of growth in MRS w/o bile. Table S6: Statistical analysis of hydrogen peroxide production at 3 h% of comparator strain. Table S7: Statistical analysis of epithelial cell adhesion % of adhesion of comparator. Table S8: Statistical analysis of average A antigen adhesion % of adhesion of comparator. Table S9: Statistical analysis of average B antigen adhesion % of adhesion of comparator. Table S10: Statistical analysis of average H antigen adhesion % of adhesion of comparator.

Author Contributions

Conceptualization, H.A., H.M., S.D.F., P.W., J.M., A.C.O. and S.L.; methodology, H.A., S.D.F., H.M., P.W., A.C.O. and S.L.; formal analysis, H.A., I.A., S.D.F., H.M. and P.W.; investigation, H.A. and H.M.; writing—original draft preparation, H.A.; writing—review and editing, all authors; statistical analysis and visualization, H.A. and I.A.; supervision, J.M., A.C.O., S.L. and L.L.; project administration, J.M. and S.L.; funding acquisition, S.L. and L.L. All authors have read and agreed to the published version of the manuscript.

Funding

The study was funded by IFF Health and Biosciences.

Institutional Review Board Statement

Fecal sample collection was approved by the Helsinki University Hospital EC (ethical permission 229/E0/07).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

Not applicable.

Acknowledgments

We thank Henri Ahokoski and Jaana Larsson-Leskelä from IFF Health and Biosciences, Global Health and Nutrition Science, Kantvik, Finland, for their valuable technical expertise.

Conflicts of Interest

H.A., S.D.F., S.L., A.C.O. and L.L. are current or former employees of Danisco Sweeteners Oy, part of IFF Health and Biosciences, which manufactures, markets, and sells the commercial strains that were used in the study. The statistical analysis that was conducted by I.A. (Vincit Oyj) was sponsored by IFF Health and Biosciences.

References

  1. Hill, C.; Guarner, F.; Reid, G.; Gibson, G.R.; Merenstein, D.J.; Pot, B.; Morelli, L.; Canani, R.B.; Flint, H.J.; Salminen, S.; et al. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol. 2014, 11, 506–514. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Sanders, M.E.; Akkermans, L.M.; Haller, D.; Hammerman, C.; Heimbach, J.; Hörmannsperger, G.; Huys, G.; Levy, D.D.; Lutgendorff, F.; Mack, D.; et al. Safety assessment of probiotics for human use. Gut Microbes 2010, 1, 164–185. [Google Scholar] [CrossRef] [PubMed]
  3. Saarela, M.; Mogensen, G.; Fonden, R.; Matto, J.; Mattila-Sandholm, T. Probiotic bacteria: Safety, functional and technological properties. J. Biotechnol. 2000, 84, 197–215. [Google Scholar] [CrossRef] [PubMed]
  4. Bermudez-Brito, M.; Plaza-Díaz, J.; Muñoz-Quezada, S.; Gómez-Llorente, C.; Gil, A. Probiotic Mechanisms of Action. Ann. Nutr. Metab. 2012, 61, 160–174. [Google Scholar] [CrossRef]
  5. Forssten, S.D.; Ouwehand, A.C. Contribution of the microbiota to healthy aging. In Comprehensive Gut Microbiota; Changes of Microbiota During Host Lifespan and Development; Glibetic, M., Ed.; Elsevier: Amsterdam, The Netherlands, 2021; Volume 2, pp. 69–84. [Google Scholar]
  6. Lehtoranta, L.; Ala-Jaakkola, R.; Laitila, A.; Maukonen, J. Healthy Vaginal Microbiota and Influence of Probiotics Across the Female Life Span. Front. Microbiol. 2022, 13, 819958. [Google Scholar] [CrossRef]
  7. Huttenhower, C.; Gevers, D.; Knight, R.; Abubucker, S.; Badger, J.H.; Chinwalla, A.T.; Creasy, H.H.; Earl, A.M.; FitzGerald, M.G.; Fulton, R.S.; et al. Structure, function and diversity of the healthy human microbiome. Nature 2012, 486, 207–214. [Google Scholar] [CrossRef] [Green Version]
  8. Amabebe, E.; Anumba, D.O.C. The Vaginal Microenvironment: The Physiologic Role of Lactobacilli. Front. Med. 2018, 5, 181. [Google Scholar] [CrossRef] [Green Version]
  9. Kovachev, S. Defence factors of vaginal lactobacilli. Crit. Rev. Microbiol. 2018, 44, 31–39. [Google Scholar] [CrossRef]
  10. Barrientos-Duran, A.; Fuentes-Lopez, A.; de Salazar, A.; Plaza-Diaz, J.; Garcia, F. Reviewing the Composition of Vaginal Microbiota: Inclusion of Nutrition and Probiotic Factors in the Maintenance of Eubiosis. Nutrients 2020, 12, 419. [Google Scholar] [CrossRef] [Green Version]
  11. McFarland, L.V.; Evans, C.T.; Goldstein, E.J.C. Strain-Specificity and Disease-Specificity of Probiotic Efficacy: A Systematic Review and Meta-Analysis. Front. Med. 2018, 5, 124. [Google Scholar] [CrossRef]
  12. De Mattos, L.C. Structural diversity and biological importance of ABO, H, Lewis and secretor histo-blood group carbohydrates. Rev. Bras. Hematol. E Hemoter. 2016, 38, 331–340. [Google Scholar] [CrossRef] [Green Version]
  13. Wacklin, P.; Mäkivuokko, H.; Alakulppi, N.; Nikkilä, J.; Tenkanen, H.; Räbinä, J.; Partanen, J.; Aranko, K.; Mättö, J. Secretor Genotype (FUT2 gene) Is Strongly Associated with the Composition of Bifidobacteria in the Human Intestine. PLoS ONE 2011, 6, e20113. [Google Scholar] [CrossRef] [Green Version]
  14. Wacklin, P.; Tuimala, J.; Nikkilä, J.; Sebastian, T.; Mäkivuokko, H.; Alakulppi, N.; Laine, P.; Rajilic-Stojanovic, M.; Paulin, L.; De Vos, W.M.; et al. Faecal Microbiota Composition in Adults Is Associated with the FUT2 Gene Determining the Secretor Status. PLoS ONE 2014, 9, e94863. [Google Scholar] [CrossRef] [Green Version]
  15. Uchida, H.; Fujitani, K.; Kawai, Y.; Kitazawa, H.; Horii, A.; Shiiba, K.; Saito, K.; Saito, T. A new assay using surface plasmon resonance (SPR) to determine binding of the Lactobacillus acidophilus group to human colonic mucin. Biosci. Biotechnol. Biochem. 2004, 68, 1004–1010. [Google Scholar] [CrossRef] [Green Version]
  16. Saarela, M.H.; Alakomi, H.L.; Puhakka, A.; Matto, J. Effect of the fermentation pH on the storage stability of Lactobacillus rhamnosus preparations and suitability of in vitro analyses of cell physiological functions to predict it. J. Appl. Microbiol. 2009, 106, 1204–1212. [Google Scholar] [CrossRef]
  17. Capurso, L. Thirty Years of Lactobacillus rhamnosus GG A Review. J. Clin. Gastroenterol. 2019, 53, S1–S41. [Google Scholar] [CrossRef]
  18. Apajalahti, J.H.; Kettunen, H.; Kettunen, A.; Holben, W.E.; Nurminen, P.H.; Rautonen, N.; Mutanen, M. Culture-independent microbial community analysis reveals that inulin in the diet primarily affects previously unknown bacteria in the mouse cecum. Appl. Environ. Microbiol. 2002, 68, 4986–4995. [Google Scholar] [CrossRef] [Green Version]
  19. Ward, J.H. Hierarchical Grouping to Optimize an Objective Function. J. Am. Stat. Assoc. 1963, 58, 236–244. [Google Scholar] [CrossRef]
  20. Hollander, M.; Wolfe, D.A. Nonparametric Statistical Methods; John Wiley and Sons: New York, NY, USA, 1973. [Google Scholar]
  21. Balkus, J.E.; Mitchell, C.; Agnew, K.; Liu, C.; Fiedler, T.; Cohn, S.E.; Luque, A.; Coombs, R.; Fredricks, D.N.; Hitti, J. Detection of hydrogen peroxide-producing Lactobacillus species in the vagina: A comparison of culture and quantitative PCR among HIV-1 seropositive women. BMC Infect. Dis. 2012, 12, 188. [Google Scholar] [CrossRef] [Green Version]
  22. Uchida, H.; Kinoshita, H.; Kawai, Y.; Kitazawa, H.; Miura, K.; Shiiba, K.; Horii, A.; Kimura, K.; Taketomo, N.; Oda, M.; et al. Lactobacilli binding human A-antigen expressed in intestinal mucosa. Res. Microbiol. 2006, 157, 659–665. [Google Scholar] [CrossRef]
  23. Pino, A.; Bartolo, E.; Caggia, C.; Cianci, A.; Randazzo, C.L. Detection of vaginal lactobacilli as probiotic candidates. Sci. Rep. 2019, 9, 3355. [Google Scholar] [CrossRef] [Green Version]
  24. Pino, A.; Rapisarda, A.M.C.; Vitale, S.G.; Cianci, S.; Caggia, C.; Randazzo, C.L.; Cianci, A. A clinical pilot study on the effect of the probiotic Lacticaseibacillus rhamnosus TOM 22.8 strain in women with vaginal dysbiosis. Sci. Rep. 2021, 11, 2592. [Google Scholar] [CrossRef]
  25. Sengupta, R.; Altermann, E.; Anderson, R.C.; McNabb, W.C.; Moughan, P.J.; Roy, N.C. The Role of Cell Surface Architecture of Lactobacilli in Host-Microbe Interactions in the Gastrointestinal Tract. Mediators Inflamm. 2013, 2013, 37921. [Google Scholar] [CrossRef] [Green Version]
  26. Ruiz, L.; Margolles, A.; Sánchez, B. Bile resistance mechanisms in Lactobacillus and Bifidobacterium. Front. Microbiol. 2013, 4, 396. [Google Scholar] [CrossRef] [Green Version]
  27. Sánchez, B.; Ruiz, L.; Gueimonde, M.; Ruas-Madiedo, P.; Margolles, A. Toward improving technological and functional properties of probiotics in foods. Trends Food Sci. Technol. 2012, 26, 56–63. [Google Scholar] [CrossRef]
  28. Fenster, K.; Freeburg, B.; Hollard, C.; Wong, C.; Rønhave Laursen, R.; Ouwehand, A. The Production and Delivery of Probiotics: A Review of a Practical Approach. Microorganisms 2019, 7, 83. [Google Scholar] [CrossRef] [Green Version]
  29. Alp, D.; Kuleaşan, H. Adhesion mechanisms of lactic acid bacteria: Conventional and novel approaches for testing. World J. Microbiol. Biotechnol. 2019, 35, 156. [Google Scholar] [CrossRef]
  30. Cooling, L. Blood Groups in Infection and Host Susceptibility. Clin. Microbiol. Rev. 2015, 28, 801–870. [Google Scholar] [CrossRef] [Green Version]
  31. Ravn, V.; Dabelsteen, E. Tissue distribution of histo-blood group antigens. APMIS 2000, 108, 1–28. [Google Scholar] [CrossRef]
  32. Stowell, C.P.; Stowell, S.R. Biologic roles of the ABH and Lewis histo-blood group antigens Part I: Infection and immunity. Vox Sang. 2019, 114, 426–442. [Google Scholar] [CrossRef]
  33. Borén, T.; Falk, P.; Roth, K.A.; Larson, G.; Normark, S. Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science 1993, 262, 1892–1895. [Google Scholar] [CrossRef] [PubMed]
  34. Marionneau, S.; Ruvoen, N.; Le Moullac-Vaidye, B.; Clement, M.; Cailleau-Thomas, A.; Ruiz-Palacois, G.; Huang, P.W.; Jiang, X.; Le Pendu, J. Norwalk virus binds to histo-blood group antigens present on gastroduodenal epithelial cells of secretor individuals. Gastroenterology 2002, 122, 1967–1977. [Google Scholar] [CrossRef] [PubMed]
  35. de Rougemont, A.; Ruvoen-Clouet, N.; Simon, B.; Estienney, M.; Elie-Caille, C.; Aho, S.; Pothier, P.; Le Pendu, J.; Boireau, W.; Belliot, G. Qualitative and quantitative analysis of the binding of GII.4 norovirus variants onto human blood group antigens. J. Virol. 2011, 85, 4057–4070. [Google Scholar] [CrossRef] [Green Version]
  36. Hu, L.; Sankaran, B.; Laucirica, D.R.; Patil, K.; Salmen, W.; Ferreon, A.C.M.; Tsoi, P.S.; Lasanajak, Y.; Smith, D.F.; Ramani, S.; et al. Glycan recognition in globally dominant human rotaviruses. Nat. Commun. 2018, 9, 2631. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  37. Watanabe, M.; Kinoshita, H.; Huang, I.N.; Eguchi, K.; Tsurumi, T.; Kawai, Y.; Kitazawa, H.; Kimura, K.; Taketomo, N.; Kikuchi, D.; et al. An Adhesin-Like Protein, Lam29, fromLactobacillus mucosaeME-340 Binds to Histone H3 and Blood Group Antigens in Human Colonic Mucus. Biosci. Biotechnol. Biochem. 2012, 76, 1655–1660. [Google Scholar] [CrossRef] [Green Version]
  38. Watanabe, M.; Kinoshita, H.; Nitta, M.; Yukishita, R.; Kawai, Y.; Kimura, K.; Taketomo, N.; Yamazaki, Y.; Tateno, Y.; Miura, K.; et al. Identification of a new adhesin-like protein from Lactobacillus mucosae ME-340 with specific affinity to the human blood group A and B antigens. J. Appl. Microbiol. 2010, 109, 927–935. [Google Scholar] [CrossRef]
  39. Kinoshita, H.; Wakahara, N.; Watanabe, M.; Kawasaki, T.; Matsuo, H.; Kawai, Y.; Kitazawa, H.; Ohnuma, S.; Miura, K.; Horii, A.; et al. Cell surface glyceraldehyde-3-phosphate dehydrogenase (GAPDH) of Lactobacillus plantarum LA 318 recognizes human A and B blood group antigens. Res. Microbiol. 2008, 159, 685–691. [Google Scholar] [CrossRef]
  40. Houeix, B.; Synowsky, S.; Cairns, M.T.; Kane, M.; Kilcoyne, M.; Joshi, L. Identification of putative adhesins and carbohydrate ligands of Lactobacillus paracasei using a combinatorial in silico and glycomics microarray profiling approach. Integr. Biol. 2019, 11, 315–329. [Google Scholar] [CrossRef]
  41. Mäkivuokko, H.; Lahtinen, S.J.; Wacklin, P.; Tuovinen, E.; Tenkanen, H.; Nikkilä, J.; Björklund, M.; Aranko, K.; Ouwehand, A.C.; Mättö, J. Association between the ABO blood group and the human intestinal microbiota composition. BMC Microbiol. 2012, 12, 94. [Google Scholar] [CrossRef] [Green Version]
  42. Davenport, E.R.; Goodrich, J.K.; Bell, J.T.; Spector, T.D.; Ley, R.E.; Clark, A.G. ABO antigen and secretor statuses are not associated with gut microbiota composition in 1500 twins. BMC Genom. 2016, 17, 941. [Google Scholar] [CrossRef]
  43. Mäkivuokko, H.; Wacklin, P.; Koenen, M.E.; Laamanen, K.; Alakulppi, N.; Venema, K.; Mättö, J. Isolation of bifidobacteria for blood group secretor status targeted personalised nutrition. Microb. Ecol. Health Dis. 2012, 23, 18578. [Google Scholar] [CrossRef] [PubMed]
  44. Fiocco, D.; Longo, A.; Arena, M.P.; Russo, P.; Spano, G.; Capozzi, V. How probiotics face food stress: They get by with a little help. Crit. Rev. Food Sci. Nutr. 2020, 60, 1552–1580. [Google Scholar] [CrossRef] [PubMed]
  45. Ravel, J.; Gajer, P.; Abdo, Z.; Schneider, G.M.; Koenig, S.S.K.; McCulle, S.L.; Karlebach, S.; Gorle, R.; Russell, J.; Tacket, C.O.; et al. Vaginal microbiome of reproductive-age women. Proc. Natl. Acad. Sci. USA 2011, 108, 4680–4687. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  46. Boris, S.; Barbes, C. Role played by lactobacilli in controlling the population of vaginal pathogens. Microb. Infect. 2000, 2, 543–546. [Google Scholar] [CrossRef] [PubMed]
  47. Tachedjian, G.; O’Hanlon, D.E.; Ravel, J. The implausible “in vivo” role of hydrogen peroxide as an antimicrobial factor produced by vaginal microbiota. Microbiome 2018, 6, 29. [Google Scholar] [CrossRef] [Green Version]
  48. Antonio, M.A.; Hawes, S.E.; Hillier, S.L. The identification of vaginal Lactobacillus species and the demographic and microbiologic characteristics of women colonized by these species. J. Infect. Dis. 1999, 180, 1950–1956. [Google Scholar] [CrossRef] [Green Version]
  49. Aroutcheva, A.; Gariti, D.; Simon, M.; Shott, S.; Faro, J.; Simoes, J.A.; Gurguis, A.; Faro, S. Defense factors of vaginal lactobacilli. Am. J. Obstet. Gynecol. 2001, 185, 375–379. [Google Scholar] [CrossRef] [PubMed]
  50. Eschenbach, D.A.; Davick, P.R.; Williams, B.L.; Klebanoff, S.J.; Young-Smith, K.; Critchlow, C.M.; Holmes, K.K. Prevalence of hydrogen peroxide-producing Lactobacillus species in normal women and women with bacterial vaginosis. J. Clin. Microbiol. 1989, 27, 251–256. [Google Scholar] [CrossRef] [Green Version]
  51. Pramanick, R.; Aranha, C. Distinct Functional Traits of Lactobacilli from Women with Asymptomatic Bacterial Vaginosis and Normal Microbiota. Microorganisms 2020, 8, 1949. [Google Scholar] [CrossRef]
  52. Vaneechoutte, M. Lactobacillus iners, the unusual suspect. Res. Microbiol. 2017, 168, 826–836. [Google Scholar] [CrossRef]
  53. Alonzo Martínez, M.C.; Cazorla, E.; Cánovas, E.; Martínez-Blanch, J.F.; Chenoll, E.; Climent, E.; Navarro-López, V. Study of the Vaginal Microbiota in Healthy Women of Reproductive Age. Microorganisms 2021, 9, 1069. [Google Scholar] [CrossRef] [PubMed]
  54. Petrova, M.I.; Reid, G.; Vaneechoutte, M.; Lebeer, S. Lactobacillus iners: Friend or Foe? Trends Microbiol. 2017, 25, 182–191. [Google Scholar] [CrossRef] [PubMed]
  55. Mastromarino, P.; Vitali, B.; Mosca, L. Bacterial vaginosis: A review on clinical trials with probiotics. New Microbiol. 2013, 36, 229–238. [Google Scholar] [PubMed]
  56. Ravel, J.; Moreno, I.; Simón, C. Bacterial vaginosis and its association with infertility, endometritis, and pelvic inflammatory disease. Am. J. Obstet. Gynecol. 2021, 224, 251–257. [Google Scholar] [CrossRef]
  57. Li, C.; Wang, T.; Li, Y.; Zhang, T.; Wang, Q.; He, J.; Wang, L.; Li, L.; Yang, N.; Fang, Y. Probiotics for the treatment of women with bacterial vaginosis: A systematic review and meta-analysis of randomized clinical trials. Eur. J. Pharmacol. 2019, 864, 172660. [Google Scholar] [CrossRef]
  58. Petrova, M.I.; Lievens, E.; Malik, S.; Imholz, N.; Lebeer, S. Lactobacillus species as biomarkers and agents that can promote various aspects of vaginal health. Front. Physiol. 2015, 6, 81. [Google Scholar] [CrossRef] [Green Version]
  59. Liong, M.T.; Shah, N.P. Acid and bile tolerance and cholesterol removal ability of lactobacilli strains. J. Dairy Sci. 2005, 88, 55–66. [Google Scholar] [CrossRef] [Green Version]
  60. Koskenniemi, K.; Laakso, K.; Koponen, J.; Kankainen, M.; Greco, D.; Auvinen, P.; Savijoki, K.; Nyman, T.A.; Surakka, A.; Salusjärvi, T.; et al. Proteomics and transcriptomics characterization of bile stress response in probiotic Lactobacillus rhamnosus GG. Mol. Cell. Proteomics 2011, 10, S1–S18. [Google Scholar] [CrossRef] [Green Version]
  61. van de Guchte, M.; Serror, P.; Chervaux, C.; Smokvina, T.; Ehrlich, S.D.; Maguin, E. Stress responses in lactic acid bacteria. Antonie Van Leeuwenhoek 2002, 82, 187–216. [Google Scholar] [CrossRef]
Figure 1. Probiotic characteristics: growth, acid, and bile tolerance, as well as H2O2 production and adhesion characteristics at the species level. (A) MRS growth, OD600; (B) acid tolerance in pH 3.5, log reduction; (C) acid tolerance in pH 2.5, log reduction; (D) bile tolerance in 0.3% oxgall, % growth in MRS without (w/o) bile; (E) bile tolerance in 0.9% oxgall, % growth in MRS w/o bile; (F) H2O2 production expressed as H2O2 production in relation to comparator strain L. jensenii DSM 20557 after 3 h; (G) vaginal epithelial cell adhesion, percentage (%) of adhesion of L. jensenii LX11796; (H) average A-antigen adhesion, % of adhesion of L. crispatus LMG 18204; (I) average B-antigen adhesion, % of adhesion of L. crispatus LMG 18204; and (J) average H-antigen adhesion, % of adhesion of L. crispatus LMG 18204. Mean ± SD values from species with two or more strains in the panel, as well as the individual values of each strain of a particular species, are shown. The acid tolerance data at pH 3.5 in Figure 1B are missing from L. acidophilus LA11897, L. amylovorus LX11898, L. paracasei LC11896, and L. ruminis LX11894. Furthermore, L. paracasei and L. plantarum species are omitted from Figure 1F, as they did not produce H2O2. Two L. iners strains from the panel did not grow and were omitted from the analysis. The dashed line in (AE) indicates the value obtained from the control strain L. rhamnosus GG. The dashed line in (F) indicates the value obtained from the comparator strain L. jensenii DSM 20557, in Figure 1G the comparator strain L. jensenii LX11796 and in (HJ) the adhesion of comparator strain L. crispatus LMG18199, that is known to adhere well to the A blood group antigen.
Figure 1. Probiotic characteristics: growth, acid, and bile tolerance, as well as H2O2 production and adhesion characteristics at the species level. (A) MRS growth, OD600; (B) acid tolerance in pH 3.5, log reduction; (C) acid tolerance in pH 2.5, log reduction; (D) bile tolerance in 0.3% oxgall, % growth in MRS without (w/o) bile; (E) bile tolerance in 0.9% oxgall, % growth in MRS w/o bile; (F) H2O2 production expressed as H2O2 production in relation to comparator strain L. jensenii DSM 20557 after 3 h; (G) vaginal epithelial cell adhesion, percentage (%) of adhesion of L. jensenii LX11796; (H) average A-antigen adhesion, % of adhesion of L. crispatus LMG 18204; (I) average B-antigen adhesion, % of adhesion of L. crispatus LMG 18204; and (J) average H-antigen adhesion, % of adhesion of L. crispatus LMG 18204. Mean ± SD values from species with two or more strains in the panel, as well as the individual values of each strain of a particular species, are shown. The acid tolerance data at pH 3.5 in Figure 1B are missing from L. acidophilus LA11897, L. amylovorus LX11898, L. paracasei LC11896, and L. ruminis LX11894. Furthermore, L. paracasei and L. plantarum species are omitted from Figure 1F, as they did not produce H2O2. Two L. iners strains from the panel did not grow and were omitted from the analysis. The dashed line in (AE) indicates the value obtained from the control strain L. rhamnosus GG. The dashed line in (F) indicates the value obtained from the comparator strain L. jensenii DSM 20557, in Figure 1G the comparator strain L. jensenii LX11796 and in (HJ) the adhesion of comparator strain L. crispatus LMG18199, that is known to adhere well to the A blood group antigen.
Microorganisms 11 00329 g001
Figure 2. (A) Correlation of the adherence to A, B, and H antigens. (B) Standardized measures of antigen adhesion. (C) The top 10 strains with the greatest standard deviation (SD > 0.58). (D) Strains with the highest median adhesion to the three antigens.
Figure 2. (A) Correlation of the adherence to A, B, and H antigens. (B) Standardized measures of antigen adhesion. (C) The top 10 strains with the greatest standard deviation (SD > 0.58). (D) Strains with the highest median adhesion to the three antigens.
Microorganisms 11 00329 g002
Figure 3. (A) Nine clusters formed from the rank-ordered data of the 98 strains using hierarchical clustering with Ward’s method. The numbers indicating the strains are depicted in Table 1. The quantity of bacteria in different clusters is as follows: cluster 1: 14; cluster 2: 12; cluster 3: 10; cluster 4: 16; cluster 5: 8; cluster 6: 14; cluster 7: 6; cluster 8: 7; and cluster 9: 11. (B) The biological parameters measured from the strains in each cluster represented by box plots. The box shows the interquartile range, the line inside the box indicates the median, whiskers indicate the minimum and the maximum values, and dots represent the outliers.
Figure 3. (A) Nine clusters formed from the rank-ordered data of the 98 strains using hierarchical clustering with Ward’s method. The numbers indicating the strains are depicted in Table 1. The quantity of bacteria in different clusters is as follows: cluster 1: 14; cluster 2: 12; cluster 3: 10; cluster 4: 16; cluster 5: 8; cluster 6: 14; cluster 7: 6; cluster 8: 7; and cluster 9: 11. (B) The biological parameters measured from the strains in each cluster represented by box plots. The box shows the interquartile range, the line inside the box indicates the median, whiskers indicate the minimum and the maximum values, and dots represent the outliers.
Microorganisms 11 00329 g003
Table 1. List of lactobacilli strains that were screened in the study, as well as their commercial category and source. For strains marked with an asterisk (*), the taxonomic classification to a species was not absolutely certain. Strains marked with a hashtag (#) did not grow under laboratory conditions and were excluded from future studies. The category in the table indicates whether the strain is commercial (Com.) or non-commercial (Non-Com.). Source in the table refers to origin of the strain as fecal (F), unknown (U), dairy (D), plant (P), or vaginal (V). The color coding and number for the various parameters measured in this study indicate the rank order of the strains in the measured parameters, with 1 (red) indicating the best-performing strain and 98 (blue) indicating the worst-performing strain.
Table 1. List of lactobacilli strains that were screened in the study, as well as their commercial category and source. For strains marked with an asterisk (*), the taxonomic classification to a species was not absolutely certain. Strains marked with a hashtag (#) did not grow under laboratory conditions and were excluded from future studies. The category in the table indicates whether the strain is commercial (Com.) or non-commercial (Non-Com.). Source in the table refers to origin of the strain as fecal (F), unknown (U), dairy (D), plant (P), or vaginal (V). The color coding and number for the various parameters measured in this study indicate the rank order of the strains in the measured parameters, with 1 (red) indicating the best-performing strain and 98 (blue) indicating the worst-performing strain.
NumTaxonomic SpeciesStrainCategorySourceBile Tolerance 0.3%
Oxgall
Bile Tolerance 0.9%
Oxgall
Acid Tolerance pH 2.5Acid Tolerance pH 3.5Growth in MRSA Adhe-sionB Adhe-sionH Adhe-sionVEC Adhe-sionH2O2
1Lactobacillus acidophilusNCFMCom.F1662149394648448137
2Lactobacillus acidophilusLA11871Non-com.F1484743713691946442
3Lactobacillus acidophilus *LA0893Non-com.F97899111164263428334
4Lactobacillus acidophilusLA11883Non-com.F1513252432239155643
5Lactobacillus acidophilusLA11890Non-com.F572617767969491 55
6Lactobacillus acidophilusLA11892Non-com.F18191363487476334238
7Lactobacillus acidophilusLA11897Non-com.F222027 468681827247
8Lactobacillus acidophilus74-2Com.F821982664343418639
9Lactobacillus acidophilusLA1076Non-com.F2091659385858466848
10Lactobacillus acidophilusLA11884Non-com.F24153266351938526512
11Lactobacillus acidophilusLa-14Com.F2112446436566255515
12Lactobacillus acidophilusLA11880Non-com.F2516397861815104820
13Lactobacillus acidophilusLA11872Non-com.F12104172682226126345
14Lactobacillus amylovorusLX11898Non-com.F376398 89221815796
15Lactobacillus amylovorusLX11891Non-com.F26189051299393934725
16Levilactobacillus brevisLbr-35Com.U11246956706430541698
17Levilactobacillus brevisLX11864Non-com.F3527836565101818349
18Levilactobacillus brevisLX11860Non-com.F3338958185302831498
19Lacticaseibacillus caseiLc-11Com.D7668294898980827898
20Lacticaseibacillus paracaseiLC11896Non-com.F675450 498077728798
21Lacticaseibacillus rhamnosusLC11868Non-com.F80977239731834297598
22Lactobacillus crispatusLX1307Non-com.U8187937522908986327
23Lactobacillus crispatusLX1220Non-com.U8776547143616862128
24Lactobacillus crispatusLX1308Non-com.U85967167414850619332
25Limosilactobacillus fermentum238Non-com.U2759489158686848098
26Limosilactobacillus fermentum508Non-com.U321612947770828851
27Lactobacillus crispatusLX0152Non-com.U40468253218875743629
28Latilactobacillus curvatus360Non-com.U86825193936852423398
29Lactobacillus acidophilusLX11873Non-com.F732325723022203154
30Lactobacillus acidophilusLX11850Non-com.F19116316849694927050
31Lactobacillus delbrueckii spp.bulgaricusLB0064Com.D91904530348282577731
32Limosilactobacillus fermentumLX11852Non-com.F42308955792238928
33Limosilactobacillus fermentumLX11853Non-com.F42318531782112240
34Limosilactobacillus fermentumLX11865Non-com.F43378773762231324
35Limosilactobacillus fermentumSBS-1Com.U2833588527339709098
36Limosilactobacillus fermentumLX1312Non-com.U706755176872664513
37Limosilactobacillus fermentumLX11866Non-com.F82838470865434315
38Limosilactobacillus fermentum2342Non-com.U3934157585357503898
39Limosilactobacillus reuteri1753Non-com.U9754662594840527
40Limosilactobacillus fermentum1924Non-com.U1732563427984753798
41Lactobacillus gasseriLG11859Non-com.F470727878226244618
42Lactobacillus gasseri811Non-com.U836696130676660239
43Lactobacillus gasseriLG0179Non-com.U64711144604746381133
44Lactobacillus gasseriLg-36Com.F7269314637762566698
45Lactobacillus johnsoniiLG0883Non-com.U7978440446668722111
46Lactobacillus gasseriLG11895Non-com.F3080868533837445530
47Lactobacillus gasseriLG11876Non-com.F69651023976878816714
48Lactobacillus johnsoniiLG0884Non-com.U3277274272824213517
49Lactobacillus helveticusLH0138Com.D88867728459090882821
50Lactobacillus jensenii911Non-com.U897981908287867273
51Limosilactobacillus mucosaeLX11854Non-com.F11645891363428571
52Limosilactobacillus mucosaeLX11893Non-com.F13530574537872272
53Lacticaseibacillus paracaseiLpc-37Com.D71623445256054534198
54Lactiplantibacillus plantarumLp-115Com.P2314533657072599298
55Lactiplantibacillus plantarumLX11855Non-com.F31287969699797961898
56Lactiplantibacillus plantarumLX11878Non-com.F1017668629898972998
57Lactiplantibacillus plantarumLX11861Non-com.F29256079109657498
58Lactiplantibacillus plantarumLX11856Non-com.F646584372628187198
59Lacticaseibacillus rhamnosusLX11869Non-com.F5349463733108105456
60Lacticaseibacillus rhamnosusLX11870Non-com.F5681731096746876198
61Lacticaseibacillus paracaseiLX11886Non-com.F36353150479426336998
62Lacticaseibacillus paracaseiLX11858Non-com.F625074348412768298
63Lacticaseibacillus rhamnosusLX11875Non-com.F6660612123292228962
64Lacticaseibacillus rhamnosusHN001Com.D4456201741858643457
65Lacticaseibacillus rhamnosusLX11888Non-com.F74611447887486645261
66Lacticaseibacillus rhamnosusLX11867Non-com.F49443738315452106063
67Lacticaseibacillus rhamnosusLX11882Non-com.F8474246261518217398
68Lacticaseibacillus rhamnosusLX11863Non-com.F59554062181810182658
69Lacticaseibacillus rhamnosusLX11851Non-com.F55575222202222143960
70Lacticaseibacillus rhamnosusLr-32Com.U38472232112112689598
71Lacticaseibacillus paracaseiLX11885Non-com.F4741364125055968598
72Lacticaseibacillus rhamnosusLX11874Non-com.F61514319246696166352
73Lacticaseibacillus rhamnosusLX11877Non-com.F50453320281813365898
74Lacticaseibacillus rhamnosusLX11879Non-com.F52422854132234172598
75Lacticaseibacillus paracaseiLX11887Non-com.F63521226571222 298
76Lacticaseibacillus rhamnosusLX11862Non-com.F51483533192428242498
77Lacticaseibacillus rhamnosusLX11857Non-com.F45365935173015129198
78Lacticaseibacillus rhamnosus1704Non-com.U4653684136665552098
79Lacticaseibacillus rhamnosusLX11881Non-com.F544317214868859
80Lacticaseibacillus paracaseiLX11849Non-com.F77941818813616885998
81Lacticaseibacillus rhamnosusLX11889Non-com.F48402676773292905398
82Lacticaseibacillus rhamnosusLR1049Non-com.U6058781361612101598
83Ligilactobacillus ruminisLX11894Non-com.F682976 564648464419
84Ligilactobacillus salivariusLs-33Com.U3464881515856488498
85Lactococcus lactisLI-23Com.D9385806055455334404
86Lactobacillus crispatusLX11211Non-com.V78755792983229244944
87Lactobacillus crispatusLX11797Non-com.V75724952645258751023
88Lactobacillus crispatusLX12212Non-com.V73847542546042403046
89Lactobacillus crispatusLX11798Non-com.V90956729803936281726
90Lactobacillus crispatusLX11799Non-com.V5873868351434436135
91Lactobacillus iners#Li25-34Non-com.V
92Lactobacillus inersLi19-22Non-com.V2236285957672669753
93Lactobacillus inersLi21-23Non-com.V5227080907876649698
94Lactobacillus iners#Li22-26Non-com.V
95Lactobacillus inersLi14-7Non-com.V65394289924040367698
96Lactobacillus jenseniiLX11794Non-com.V96923891406042511910
97Lactobacillus jenseniiLX11795Non-com.V98989687595064521441
98Lactobacillus jenseniiLX12216Non-com.V92919257757273789416
99Lactobacillus jenseniiLX12217Non-com.V95939794508480845036
100Lactobacillus jenseniiLX11796Non-com.V9488948883888878622
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Anglenius, H.; Mäkivuokko, H.; Ahonen, I.; Forssten, S.D.; Wacklin, P.; Mättö, J.; Lahtinen, S.; Lehtoranta, L.; Ouwehand, A.C. In Vitro Screen of Lactobacilli Strains for Gastrointestinal and Vaginal Benefits. Microorganisms 2023, 11, 329. https://doi.org/10.3390/microorganisms11020329

AMA Style

Anglenius H, Mäkivuokko H, Ahonen I, Forssten SD, Wacklin P, Mättö J, Lahtinen S, Lehtoranta L, Ouwehand AC. In Vitro Screen of Lactobacilli Strains for Gastrointestinal and Vaginal Benefits. Microorganisms. 2023; 11(2):329. https://doi.org/10.3390/microorganisms11020329

Chicago/Turabian Style

Anglenius, Heli, Harri Mäkivuokko, Ilmari Ahonen, Sofia D. Forssten, Pirjo Wacklin, Jaana Mättö, Sampo Lahtinen, Liisa Lehtoranta, and Arthur C. Ouwehand. 2023. "In Vitro Screen of Lactobacilli Strains for Gastrointestinal and Vaginal Benefits" Microorganisms 11, no. 2: 329. https://doi.org/10.3390/microorganisms11020329

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop